HealthCare Market Analysis

The global  vital sign monitoring devices market  is expected to reach USD 7.1 billion by 2025, according to a new report by Grand View Research, Inc. Continuous efforts towards new product development, spurring demand for the home healthcare services, increasing prevalence of chronic diseases and rising number of healthcare settings are driving factor for the remunerative growth of the market.  Development of comprehensive vital sign monitors which can monitor blood pressure, pulse and temperature is notable example of the development in this sector. Moreover, development of wireless and portable devices improved patient compliance is focal area of the development for the vital sign monitoring devices. The prevalence of chronic diseases is exponential over the decade, this can be accountable to the sedentary lifestyle, pollution and stress. As a result, the prevalence of diseases such as diabetes mellitus, hypertension, allergies and respiratory disorders has increased rapid

The  influenza diagnostics market  is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season. Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver ac

The global  track and trace solutions market  size is expected to reach USD 5.2 billion by 2025, according to a new report by Grand View Research, Inc. The track and trace solutions market is anticipated to witness a high growth during the forecastperiod from 2016 to 2025. The high growth is attributed to a majority of factors, such as the increasing focus of pharmaceutical & biopharmaceutical companies on ensuring brand protection. The pharmaceuticals & medical devices manufacturers encounter a major threat from counterfeit products and theft. The deployment of track and trace solution helps manufacturers enhance distribution channel efficiency and reduces the frequency of counterfeit products. Furthermore, rising adoption of track and trace solution by healthcare manufacturers would fuel the market growth in the long run. Introduction of advanced technology, such as RFID, provides fast reading and delivers high levels of security. However, the deployment cost of seriali

The  extracorporeal membrane oxygenation market  is expected to reach USD 346.1 million by 2024, according to a new report by Grand View Research, Inc. The growing number of respiratory failure cases and conditions, such as cardiopulmonary disease and Chronic Obstructive Pulmonary Disease (COPD) is anticipated to boost the market growth .  For instance, according to the U . S .  National Center for Health statistics, in the year 2014, there were about 149,205 deaths due to chronic lower respiratory disorders in the U.S.  Moreover, the increased adoption of ECMO machines in hospitals as a consequence ofthe medical community taking cognizance of the advantages related to the use of ECMO machines is anticipated to facilitate the emergence of this market during the forecast period.  Apart from the high applicability of these appliances in hospitals, technological advancements have played a pivotal role in further accelerating the usage of these devices. For instance, Medtronic’s

The  breast biopsy device market  is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive rate in the next few years. The key factors supporting the industry’s growth involve the rising awareness levels with regard to diagnostic procedures through cancer screening programs, global rise in breast cancers in women, and the high demand for less-invasive procedures. However, the degree of risk is directly proportional to the extent of procedure invasiveness. Biopsy causes pain and is a stressful procedure for patients, moreover, approximately 60% to 80% of breast biopsies in women result in a benign judgment. Therefore, women are encouraged to consult experts for a second opinion before undergoing a biopsy procedure, which is likely to hinder the growth of the market. The test type segment is categorized into needle breast biopsies and open surgical biopsies. The former

The global  smart syringes market  is expected to reach USD 10.2 billion in 2024, according to a new report by Grand View Research, Inc. In 2015, Some key factors driving the market include the rise in the patient population, the increasing number of needle stick injuries, and the spread of diseases due to unhygienic injection practices.  The injection practices and healthcare delivery standards are not uniform across the globe. The use of disposable syringes has been strongly advocated by various healthcare organizations across different countries; however, adherence to the patient safety guidelines is not adequately implemented in the LMIC (Low and Middle Income Countries).  As per the WHO records, the re-usage of syringes has boosted the infection cases of Ebola, malaria, Marburg virus, HIV, hepatitis, and other diseases in LMIC; these countries have been suffering with a huge infectious diseases burden due to the high transmission rates of blood-borne virus infections. In

Global  disposable medical sensors market  is expected to reach USD 7,543.1 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of HAIs (hospital acquired infections) and government initiatives aimed at reducing central-line associated bloodstream infections and surgical site infections in ward located and ICU patients are expected to serve the market as high impact rendering drivers. Introduction and subsequent rise in usage rates of novel technologies such as cancer tracking sensors, Hba1c sensors and MEMS pressure sensors is expected to boost future market growth. Strip sensors dominated the overall product segment in terms of revenue and were valued at USD 1,800.2 million in 2013. Increasing prevalence of chronic diseases such as diabetes, cancer and cardiovascular disorders and the consequent rise in demand for diabetes and cancer biomarkers strip sensors are some factors accounting for its large share. Global disposable medical s

The global  regulatory affairs outsourcing market  is expected to reach USD 12.4 billion by 2025, according to a new report by Grand View Research, Inc. Outsourcing of regulatory affairs functions to CROs or other individual service providers offers life science companies the benefit to achieve cost efficiency and reduce the overall approval process time by eliminating delays associated with regulatory submission requirements. These benefits are primarily driving the outsourcing trend and hence impacting the market over the forecast period. The augmenting disease prevalence in Asia Pacific and MEA regions and increasing number of clinical trials being conducted is stimulating life science companies to expand into these regions thereby increasing the demand of these services. Changing regulatory landscape especially in developing regions and stringent directive requirements in developed regions such as North America and Europe are driving the adoption of outsourcing trend in regul

The global  melanoma therapeutics market  is expected to reach USD 12.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases such as melanoma, skin cancer, and skin allergies is an important driver of the market. According to CDC, over 71,943 people were affected by melanoma in 2013. The American Cancer Society estimates that this number will go up to 87,100 in 2017, thus highlighting the need for melanoma drugs over the forecast period. Increasing number of FDA approvals and introduction of novel therapeutics with enhanced efficacy are also anticipated to present growth opportunities. Within a period of 6 years, i.e., from 2011 to 2016, around eight biologics have been approved for the treatment of this disease, which include Opdivo, Yervoy, Cotellic, Zelboraf, Keytruda, Mekinist, Tafinlar, and Imlygic. Companies are undertaking various R&D activities to find new indications for existing products and develop

The global  molecular weight marker market   is expected to reach a value of USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing investment in R&D by companies including biotechnology and biologics is the major factor that drives the growth during the forecast period. These markers are used by researchers and companies for various applications such as polymerase chain reaction (PCR), northern blotting, southern blotting, and molecular cloning. Thus, the increasing application of these products in R&D is expected to boost growth. Increasing focus on molecular biology research is another major factor supporting the growth of the molecular weight marker market. Molecular biology research is important to understand interactions between the different systems of a cell, including DNA, RNA, and protein biosynthesis & regulation. Thus, these research activities are very high in developed countries and are growing at a high pace in develo

The global  intravascular warming systems market  is expected to reach a value of USD 565.4 million by 2025, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures is the most significant factor projected to boost the growth of the market during the forecast period. According to the WHO, around 266.2 to 359.5 million surgeries were performed globally in 2012 and this number is expected to increase in the near future. This in turn results in the need for intravascular warming products pre-, intra-, and postoperatively. Rising adoption of technologically advanced medical devices by operating rooms, ICUs, and emergency rooms is another major factor contributing to the growth of the market. The manufacturers are focusing on developing better in-line intravascular warming systems, which facilitate rapid flow of normothermic blood and intravenous fluids. The portability feature of these product also facilitates convenient usage during trauma or

The global  structural heart imaging market   is expected to reach USD 25.3 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in incidence of Structural Heart Diseases (SHDs), growing awareness about diseases, and technological advancements in imaging modalities are anticipated to drive the market during the forecast period. Furthermore, clearer high-quality images are necessary for management of patients suffering from SHDs. Hence, availability of technologically advanced devices and increase in their adoption are likely to boost the market in the coming years. Echocardiogram, Magnetic Resonance Imaging (MRI) and CT are the most widely used modalities for SHI. Echocardiogram accounted for the maximum share in the SHI market in 2016 and is estimated to maintain its dominance during the forecast period. This can be attributed to the adoption of echo test as a first-line imaging technique, low cost as compared to CT & MRI, and its super

The global  medical automation market   is expected to reach USD 79.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for accuracy and reproducibility required during medical procedures is the high impact rendering driver for the medical automation market.  The rising adoption of these devices is attributed to the advantages associated with automated systems. For example, the automation of tedious tasks such as sampling, monitoring of quality, quantity, packaging and labeling, and scanning of medicines and devices, have reduced human efforts and increased speed and accuracy, which has led to increased dependency on these automated systems.  Moreover, the growing global prevalence of chronic conditions such as diabetes, cancer, arthritis, and chronic obstructive pulmonary disease (COPD) is further pushing the demand for therapeutic, laboratory and pharmacy automated medication systems, which are faster and more productive. As per t

The global  medical animation market  is expected to reach a value of USD 514.0 million by 2024, according to a new report by Grand View Research. Key factors driving the market growth include the higher adoption of medical animation marketing by medical devices manufacturers and pharmaceutical products. It helps in explaining product features and communicating associated information with end users.  The information represented by animation is more appealing and easy to transmit. These aforementioned benefits are expected to boost the usage rate in near future. In addition, the paradigm shift, in healthcare information technology, such as digitalization, is anticipated to contribute towards the market growth in the next few years. The medical animation market has gained momentum after the introduction of cloud-based platforms and 3D printing technology in healthcare.  Furthermore, the introduction of technologically advanced software for image analysis, such as Medical Image